Cardiology_Latest

2017 ACC/AHA Hypertension Guidelines: The TakeawaysClick through our topline review of the key takeaways from this long-awaited update.
The Top 5 Biomarkers in Cardiovascular Disease PreventionWhich biomarker is most useful in what situation? Find out how one cardiologist makes these decisions. Do you concur?
PCSK9 Inhibitors: A 5-Question Quiz
ECG Challenge: It's the Level of the Block that CountsThis 83-year-old man is treated only for hypertension and says he "feels like Tarzan." The routine ECG says otherwise.
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
Will PRESERVE Trial Results Shift Practice in Renal Prophylaxis?Results of the large trial, unveiled at AHA 2017, appear indisputable, but will prophylaxis with sodium bicarb and acetylcysteine yield ground?
5 Stubborn Statin Myths vs Data that Refute ThemAt AHA.17, Dr Rory Collins offered large-scale trial data to help dispel dangerous disinformation still circulating about the effects of statins.
2017 ACC/AHA Hypertension Guidelines: Case StudyClick through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.
Cardiologists Talk Concrete Application of Artificial IntelligenceTwo cardiologists respected for their technological expertise took the concept of AI from blue sky to concrete clinical examples at AHA 2017.